lansoprazole has been researched along with Thrombopenia in 4 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe a case of thrombocytopenia associated with the administration of lansoprazole." | 7.71 | Lansoprazole-induced thrombocytopenia. ( Anderson, CG; Zlabek, JA, 2002) |
| "To describe a case of thrombocytopenia associated with the administration of lansoprazole." | 3.71 | Lansoprazole-induced thrombocytopenia. ( Anderson, CG; Zlabek, JA, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Latifah, N | 1 |
| Ramadhani, M | 1 |
| Kim, H | 1 |
| Lee, WS | 1 |
| Lee, KH | 1 |
| Bae, SH | 1 |
| Kim, MK | 1 |
| Joo, YD | 1 |
| Zang, DY | 1 |
| Jo, JC | 1 |
| Lee, SM | 1 |
| Lee, JH | 2 |
| Kim, DY | 1 |
| Ryoo, HM | 1 |
| Hyun, MS | 1 |
| Kim, HJ | 1 |
| Asaumi, N | 1 |
| Niiya, K | 1 |
| Yoshida, C | 1 |
| Shibakura, M | 1 |
| Niiya, M | 1 |
| Tanimoto, M | 1 |
| Zlabek, JA | 1 |
| Anderson, CG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Helicobacter Pylori Eradication for the 1st Line Treatment of Immune Thrombocytopenic Purpura (ITP) Patients With Moderate Thrombocytopenia[NCT01255332] | 26 participants (Anticipated) | Observational | 2010-09-30 | Recruiting | |||
| Helicobacter Pylori and it's Hematological Impact[NCT03629587] | 100 participants (Actual) | Observational | 2016-09-27 | Completed | |||
| Efficacy of Helicobacter Pylori Eradication for the Treatment of Chronic or Persistent Immune Thrombocytopenic Purpura Patients With Moderate Thrombocytopenia: Multicenter Prospective Randomized Phase 3 Study[NCT03177629] | Phase 3 | 54 participants (Anticipated) | Interventional | 2017-05-23 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for lansoprazole and Thrombopenia
| Article | Year |
|---|---|
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
3 other studies available for lansoprazole and Thrombopenia
| Article | Year |
|---|---|
Pantoprazole-induced Thrombocytopenia: Unresponsive to Corticosteroid and Thrombocyte Concentrate Transfusion.
Topics: Blood Platelets; Humans; Lansoprazole; Male; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Thro | 2023 |
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; D | 2004 |
Lansoprazole-induced thrombocytopenia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Gastrointestina | 2002 |